Nusinersen (Spinraza) for Spinal Muscular Atrophy May Help Older Children: Study

WEDNESDAY, Aug. 29, 2018 -- A drug used to treat a rare and deadly muscle-wasting disease in children still improves muscle control even if treatment begins at a later age, a new study found. Spinal muscular atrophy (SMA) is a leading genetic cause...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news